NYLIM
CTEV

New York Life Investment Management’s Claritev Corp CTEV Stock Holding History

New York Life Investment Management’s Portfolio CTEV Stock Details CTEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,789
Closed -$383K – 1352
2024
Q1 		$383K Buy
11,789
+3,644
+45% +$153K ﹤0.01% 832
2023
Q4 		$469K Sell
8,145
-239
-3% -$14.5K ﹤0.01% 876
2023
Q3 		$563K Sell
8,384
-1,336
-14% -$98.7K 0.01% 752
2023
Q2 		$820K Sell
9,720
-1,216
-11% -$65K 0.01% 611
2023
Q1 		$464K Buy
+10,936
New +$494K 0.01% 1115

Other funds holding CTEV

HFCIV
H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

New York Life Investment Management's CTEV Position: Q2 2024 in Review

New York Life Investment Management sold out of Claritev Corp (CTEV) in Q2 2024, closing a stake of 11,789 shares — an estimated $383K sold.

New York Life Investment Management first reported a position in CTEV in Q1 2023 and held it in 5 quarters. The position peaked at $820K in Q2 2023. 109 funds tracked by Wall St. Rank hold CTEV as of Q2 2024.

  • New York Life Investment Management reported no remaining Claritev Corp position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 11,789 Claritev Corp shares in Q2 2024, an estimated $383K.
  • New York Life Investment Management first reported a position in Claritev Corp in Q1 2023 and held it in 5 quarters.
  • New York Life Investment Management's Claritev Corp position peaked at $820K in Q2 2023.
  • 109 funds tracked by Wall St. Rank held Claritev Corp as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.